Literature DB >> 25429419

Comparative effectiveness of bevacizumab and ranibizumab in the comparison of age-related macular degeneration treatments trials.

Andrea Messori1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25429419     DOI: 10.1001/jamaophthalmol.2014.4642

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  1 in total

1.  Analyses Comparing Visual Acuity Between Ranibizumab and Bevacizumab in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Gui-shuang Ying; Maureen G Maguire
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.